Tandem Diabetes Care
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $282,648 | $363,289 | $221,910 | $191,674 |
Gross Profit | 157,455 | 124,653 | 112,794 | 94,672 |
EBITDA | 4,215 | -16,538 | -23,842 | -33,589 |
EBIT | -30 | -20,749 | -27,949 | -37,632 |
Net Income | 755 | -23,251 | -30,814 | -42,715 |
Net Change In Cash | 282,648 | 363,289 | 221,910 | 191,674 |
Free Cash Flow | -38,756 | 21,540 | -11,741 | -12,453 |
Cash | 69,234 | 49,039 | 47,697 | 58,979 |
Basic Shares | 66,157 | 65,538 | 64,994 | 65,325 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $940,203 | $747,718 | $801,217 | $702,799 |
Gross Profit | 489,574 | 367,690 | 412,986 | 376,215 |
EBITDA | -99,127 | -194,657 | -72,314 | 36,498 |
EBIT | -99,285 | -210,372 | -86,644 | 22,653 |
Net Income | -96,025 | -222,611 | -94,594 | 15,566 |
Net Change In Cash | 940,203 | 747,718 | 801,217 | 702,799 |
Cost of Revenue | 100,509 | -23,585 | ||
Free Cash Flow | 4,994 | -83,413 | 7,512 | 87,848 |
Cash | 69,234 | 58,868 | 172,517 | 71,181 |
Basic Shares | 65,451 | 64,968 | 64,146 | 64,349 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.43 |
2024-09-30 | -$0.35 |
2024-06-30 | -$0.48 |
2024-03-31 | -$0.63 |
